NanoViricides
NNVC
#10068
Rank
NZ$46.32 M
Marketcap
NZ$2.15
Share price
-3.88%
Change (1 day)
-16.50%
Change (1 year)

NanoViricides (NNVC) - Cash on Hand

Cash on Hand as of September 2025 : NZ$1.94 Million

According to NanoViricides's latest financial reports the company has NZ$1.94 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

NanoViricides - Cash on Hand chart (from 2006 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-06-30NZ$7.86 M-40.8%
2023-06-30NZ$13.28 M-41.05%
2022-06-30NZ$22.54 M-23.13%
2021-06-30NZ$29.32 M37.99%
2020-06-30NZ$21.24 M459.12%
2019-06-30NZ$3.8 M-63.66%
2018-06-30NZ$10.45 M-49.3%
2017-06-30NZ$20.62 M-39.09%
2016-06-30NZ$33.85 M-26.97%
2015-06-30NZ$46.36 M10.71%
2014-06-30NZ$41.87 M132.73%
2013-06-30NZ$17.99 M1.16%
2012-06-30NZ$17.78 M59.75%
2011-06-30NZ$11.13 M10.73%
2010-06-30NZ$10.05 M281.6%
2009-06-30NZ$2.63 M145.56%
2008-06-30NZ$1.07 M-14.76%
2007-06-30NZ$1.25 M-69.59%
2006-06-30NZ$4.13 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
BioCryst Pharmaceuticals
BCRX
NZ$0.36 B 18,810.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
NZ$1.32 B 67,670.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$12.72 B 652,732.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$28.58 B 1,465,819.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$31.55 B 1,617,901.08%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$7.69 B 394,706.83%๐Ÿ‡ฌ๐Ÿ‡ง UK